These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1247 related items for PubMed ID: 28750639
1. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin. Hugo HJ, Gunasinghe NPAD, Hollier BG, Tanaka T, Blick T, Toh A, Hill P, Gilles C, Waltham M, Thompson EW. Breast Cancer Res; 2017 Jul 27; 19(1):86. PubMed ID: 28750639 [Abstract] [Full Text] [Related]
2. Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo. Zhang J, Li K, Zhang Y, Lu R, Wu S, Tang J, Xia Y, Sun J. BMC Cancer; 2019 Jun 10; 19(1):555. PubMed ID: 31182056 [Abstract] [Full Text] [Related]
3. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells. Hugo HJ, Pereira L, Suryadinata R, Drabsch Y, Gonda TJ, Gunasinghe NP, Pinto C, Soo ET, van Denderen BJ, Hill P, Ramsay RG, Sarcevic B, Newgreen DF, Thompson EW. Breast Cancer Res; 2013 Nov 27; 15(6):R113. PubMed ID: 24283570 [Abstract] [Full Text] [Related]
4. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer. Lei J, Fan L, Wei G, Chen X, Duan W, Xu Q, Sheng W, Wang K, Li X. Tumour Biol; 2015 Apr 27; 36(4):3119-26. PubMed ID: 25501705 [Abstract] [Full Text] [Related]
5. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells. Castillo LF, Tascón R, Lago Huvelle MR, Novack G, Llorens MC, Dos Santos AF, Shortrede J, Cabanillas AM, Bal de Kier Joffé E, Labriola L, Peters MG. Oncotarget; 2016 Sep 13; 7(37):60133-60154. PubMed ID: 27507057 [Abstract] [Full Text] [Related]
6. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo. Ziegler E, Hansen MT, Haase M, Emons G, Gründker C. Breast Cancer Res Treat; 2014 Nov 13; 148(2):269-77. PubMed ID: 25292421 [Abstract] [Full Text] [Related]
7. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin. Shah P, Gau Y, Sabnis G. Breast Cancer Res Treat; 2014 Jan 13; 143(1):99-111. PubMed ID: 24305977 [Abstract] [Full Text] [Related]
8. Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system. Wafai R, Williams ED, de Souza E, Simpson PT, McCart Reed AE, Kutasovic JR, Waltham M, Snell CE, Blick T, Thompson EW, Hugo HJ. Breast Cancer Res; 2020 Dec 04; 22(1):136. PubMed ID: 33276802 [Abstract] [Full Text] [Related]
9. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition. Su CM, Lee WH, Wu AT, Lin YK, Wang LS, Wu CH, Yeh CT. J Nutr Biochem; 2015 Jun 04; 26(6):675-85. PubMed ID: 25792283 [Abstract] [Full Text] [Related]
10. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo. Lu X, Yan C, Huang Y, Shi D, Fu Z, Qiu J, Yin Y. Oncotarget; 2016 Jun 14; 7(24):37177-37191. PubMed ID: 27184007 [Abstract] [Full Text] [Related]
11. Epithelial to mesenchymal transition is associated with rapamycin resistance. Holder AM, Akcakanat A, Adkins F, Evans K, Chen H, Wei C, Milton DR, Li Y, Do KA, Janku F, Meric-Bernstam F. Oncotarget; 2015 Aug 14; 6(23):19500-13. PubMed ID: 25944619 [Abstract] [Full Text] [Related]
12. Long Noncoding RNA TCONS_00068220 Promotes Breast Cancer Progression by Regulating Epithelial-Mesenchymal Transition Marker E-Cadherin. Liu X, Tian X. Med Sci Monit; 2021 Mar 15; 27():e929832. PubMed ID: 33716295 [Abstract] [Full Text] [Related]
13. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Ma X, Yan W, Dai Z, Gao X, Ma Y, Xu Q, Jiang J, Zhang S. Drug Des Devel Ther; 2016 Mar 15; 10():1419-41. PubMed ID: 27143851 [Abstract] [Full Text] [Related]
14. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line. Satram-Maharaj T, Nyarko JN, Kuski K, Fehr K, Pennington PR, Truitt L, Freywald A, Lukong KE, Anderson DH, Mousseau DD. Cell Signal; 2014 Dec 15; 26(12):2621-32. PubMed ID: 25152370 [Abstract] [Full Text] [Related]
15. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q. BMC Cancer; 2015 Mar 05; 15():97. PubMed ID: 25884904 [Abstract] [Full Text] [Related]
16. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT. Hu C, Li M, Guo T, Wang S, Huang W, Yang K, Liao Z, Wang J, Zhang F, Wang H. Phytomedicine; 2019 May 05; 58():152740. PubMed ID: 31005718 [Abstract] [Full Text] [Related]
17. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models. Li Y, Drabsch Y, Pujuguet P, Ren J, van Laar T, Zhang L, van Dam H, Clément-Lacroix P, Ten Dijke P. Breast Cancer Res; 2015 Feb 25; 17(1):28. PubMed ID: 25849225 [Abstract] [Full Text] [Related]
18. Fangjihuangqi Decoction inhibits MDA-MB-231 cell invasion in vitro and decreases tumor growth and metastasis in triple-negative breast cancer xenografts tumor zebrafish model. Guo Y, Fan Y, Pei X. Cancer Med; 2020 Apr 25; 9(7):2564-2578. PubMed ID: 32037729 [Abstract] [Full Text] [Related]
20. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis. Zhou H, Li J, Zhang Z, Ye R, Shao N, Cheang T, Wang S. Int J Oncol; 2016 Dec 25; 49(6):2442-2452. PubMed ID: 27748911 [Abstract] [Full Text] [Related] Page: [Next] [New Search]